Worsening US Maternal Death Rates
JAMA Medical News3 Heinä 2023

Worsening US Maternal Death Rates

The 2021 US maternal mortality rate is more than 10 times the rate of other high-income countries, according to a March 2023 CDC report. In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, is joined by Monica McLemore, PhD, MPH, RN, University of Washington, Audra Meadows, MD, MPH, UC San Diego, and Joia Crear-Perry, MD, founder and president of the National Birth Equity Collaborative, to discuss these concerning numbers and why preventable death rates are worsening in the US.

Related Content:

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(293)

The First CKM Syndrome Guidelines Are Here

The First CKM Syndrome Guidelines Are Here

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines." Related Content: What to Know About the First...

17 Heinä 5min

The Testosterone Therapy Debate

The Testosterone Therapy Debate

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?" Related Content: Testosterone ...

10 Heinä 5min

Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected

Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." ...

2 Heinä 5min

PMOS is the New PCOS

PMOS is the New PCOS

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content: PCOS Is Now ...

26 Kesä 5min

New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semagluti...

18 Kesä 22min

Why Exercise Still Matters in the GLP-1 Drug Era

Why Exercise Still Matters in the GLP-1 Drug Era

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity...

18 Kesä 4min

The Search for a Fentanyl Vaccine

The Search for a Fentanyl Vaccine

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine

12 Kesä 5min

New Insights on HFpEF in Patients With Severe Obesity

New Insights on HFpEF in Patients With Severe Obesity

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a D...

5 Kesä 4min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
rss-hereilla
docemilia
hippokrateen-vastaanotolla
rss-kasvatuspsykologiaa-kaikille
mielipaivakirja
rss-kipinoita-podcast
rss-duodecim-lehti
rss-laakaripodi
rss-tiedetta-vai-tarinaa
rss-ylistys-elaimille
rss-lihavuudesta-podcast
rss-totuuden-liepeilla